Molecular Partners Ag (MOLN) Cash from Operations (2021 - 2025)
Historic Cash from Operations for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $37.7 million.
- Molecular Partners Ag's Cash from Operations fell 24.96% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.4 million, marking a year-over-year decrease of 19744.56%. This contributed to the annual value of -$67.3 million for FY2024, which is 20125.29% down from last year.
- According to the latest figures from Q3 2025, Molecular Partners Ag's Cash from Operations is $37.7 million, which was down 24.96% from -$36.4 million recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Cash from Operations registered a high of $156.6 million during Q2 2022, and its lowest value of -$156.2 million during Q3 2022.
- Its 5-year average for Cash from Operations is $1.4 million, with a median of -$18997.2 in 2025.
- Data for Molecular Partners Ag's Cash from Operations shows a peak YoY increase of 63585.36% (in 2022) and a maximum YoY decrease of 37336.47% (in 2022) over the last 5 years.
- Quarter analysis of 5 years shows Molecular Partners Ag's Cash from Operations stood at -$98.6 million in 2021, then soared by 224.73% to $122.9 million in 2022, then crashed by 45.86% to $66.6 million in 2023, then tumbled by 201.53% to -$67.6 million in 2024, then skyrocketed by 155.75% to $37.7 million in 2025.
- Its last three reported values are $37.7 million in Q3 2025, -$36.4 million for Q2 2025, and -$18997.2 during Q1 2025.